|
original article |
Journal |
Date |
Title |
Authors All Authors |
1 |
[GO] |
Exploration of Asthma & Allergy |
2024―Jul―24 |
Impact of reduced COVID-19 restrictions on pediatric recurrent respiratory infections in Southern Italy: a cross-sectional analysis |
Cristiana Indolfi, Lorena Fortuna Izzo, Margherita Luciano, Michelangelo Mercogliano, Angela Klain, Giulio Dinardo, et al. (+2) Fabio Decimo, Michele Miraglia del Giudice |
2 |
[GO] |
Exploration of Asthma & Allergy |
2024―Jun―27 |
Prophylactic and therapeutic potential of vitamin D in asthma during the COVID-19 pandemic: the new hope? |
Maria Michelle Papamichael, Charis Katsardis |
3 |
[GO] |
Exploration of Asthma & Allergy |
2024―Feb―28 |
Predictive value of skin testing with excipients for COVID-19 vaccines |
Fabio Viggiani, Gianfranco Calogiuri, Donato Paolino, Daniel Griscti Soler, Francesco Pugliese, Ippolita Zaza, et al. (+7) Gabriella Lastella, Maria Alessandra Lassandro, Giovanna Pastore, Chiara Maria Calabrese, Virginia Nacci, Danilo Di Bona, Eustachio Nettis |
4 |
[GO] |
Exploration of Asthma & Allergy |
2023―Apr―27 |
Allergists/immunologists facing the coronavirus disease 2019 pandemic: the experience of managing a low-care setting |
Laura Franceschini, Giancarlo Landini, Alessandro Farsi |
5 |
[GO] |
Exploration of Cardiology |
2023―Oct―30 |
Cardiovascular imaging in COVID-19: insights into features and complications |
Iwona Duraj, Małgorzata Kilarska, Agnieszka Pawlos, Karina Wierzbowska-Drabik |
6 |
[GO] |
Exploration of Digital Health Technologies |
2024―Aug―12 |
Developing a multi-variate prediction model for COVID-19 from crowd-sourced respiratory voice data |
Yuyang Yan, Wafaa Aljbawi, Sami O. Simons, Visara Urovi |
7 |
[GO] |
Exploration of Digital Health Technologies |
2024―Feb―28 |
System for classifying antibody concentration against severe acute respiratory syndrome coronavirus 2 S1 spike antigen with automatic quick response generation for integration with health passports |
Apostolos Apostolakis, Dimitris Barmpakos, Sofia Mavrikou, George Marios Papaionannou, Vasileios Tsekouras, Kyriaki Hatziagapiou, et al. (+7) Eleni Koniari, Maroula Tritzali, Athanasios Michos, George P. Chrousos, Christina Kanaka-Gantenbein, Grigoris Kaltsas, Spyridon Kintzios |
8 |
[GO] |
Exploration of Drug Science |
2024―Jul―31 |
Metformin in COVID-19: a magical role beyond the hyperglycemia |
Gaurav Kumar Chaubey, Rahul Dilawari, Radheshyam Modanwal, Sharmila Talukdar, Asmita Dhiman, Manoj Raje |
9 |
[GO] |
Exploration of Drug Science |
2023―Oct―25 |
Phytochemicals for mitigating the COVID-19 crisis: evidence from pre-clinical and clinical studies |
Atri Das, Swarnali Khan, Syamal Roy, Shantanabha Das |
10 |
[GO] |
Exploration of Drug Science |
2023―Aug―29 |
Natural compounds from medicinal plants against COVID-19 |
Anton Kolodnitsky, Nikita Ionov, Irina Gravel, Vladimir Poroikov |
11 |
[GO] |
Exploration of Immunology |
2024―May―17 |
The immune response of nano carbon-based photic-driving vaccines to severe acute respiratory syndrome coronavirus 2 |
Junming Chen, Qiang Wang, Fenfen Zhang, Jianshe Yang |
12 |
[GO] |
Exploration of Immunology |
2024―Apr―18 |
Physical activity, immune system and hypertension: reflections and challenges for future pandemics based on learning from coronavirus disease 2019 |
Francisco Pitanga |
13 |
[GO] |
Exploration of Immunology |
2024―Feb―29 |
Myelitis associated with COVID-19: clinical, radiological, and laboratory characteristics |
Aleksandra Kozlova, Alina Dzharullaeva, Amir Tukhvatulin, Inessa Zakroyshchikova, Taras Simaniv, Lola Askarova, et al. (+5) Daria Eliseeva, Natalia Stoida, Ivan Kochergin, Ekaterina Baydina, Maria Zakharova |
14 |
[GO] |
Exploration of Immunology |
2024―Jan―31 |
Paradigm of immune dysregulation in coronavirus disease-2019 infection |
Om Saswat Sahoo, Karthikeyan Pethusamy, Arnab Nayek, Rashmi Minocha, Ruby Dhar, Subhradip Karmakar |
15 |
[GO] |
Exploration of Immunology |
2023―Oct―16 |
Loss of regulation of T helper 17 cells: a definitive factor for critical cases of coronavirus disease 2019 |
Miguel Angel Pardiño-Vega, Norma Estela Herrera-González |
16 |
[GO] |
Exploration of Immunology |
2023―Oct―11 |
Effect of coronavirus disease 2019 on the vaccine development paradigm |
Sezer Okay |
17 |
[GO] |
Exploration of Immunology |
2023―Aug―24 |
Trained-immunity and cross-reactivity for protection: insights from the coronavirus disease 2019 and monkeypox emergencies for vaccine development |
Amanda Izeli Portilho, Elizabeth De Gaspari |
18 |
[GO] |
Exploration of Immunology |
2023―Aug―04 |
COVID-19 induced ARDS: immunopathology and therapeutics |
Sneha Das, Tamanna Sharma, Asha Bhardwaj, Rupesh K. Srivastava |
19 |
[GO] |
Exploration of Immunology |
2023―Mar―01 |
SARS-CoV-2 infection activates the cyclic guanosine monophosphate-adenosine monophosphate synthase-stimulator of interferon genes pathway in the lung: a review |
Gislei F. Aragão, Sthefane G. Feitosa, Herlice Do Nascimento Veras, Cícero Gilmário A. P. de Lima Filho, Karinne da S. Assunção, Luana M. Arrais, Sara Lívia M. Teixeira |
20 |
[GO] |
Exploration of Immunology |
2023―Feb―27 |
Innate immune cell and severe acute respiratory syndrome coronavirus 2 interaction |
Naima G. Cortes-Perez |
21 |
[GO] |
Exploration of Immunology |
2022―Sep―21 |
Immune responses to SARS-CoV-2 infection and COVID-19 vaccines |
Basista Rabina Sharma, P. Veeranna Ravindra |
22 |
[GO] |
Exploration of Immunology |
2022―Aug―26 |
Immune network operations in COVID-19 |
Javier Burgos-Salcedo |
23 |
[GO] |
Exploration of Immunology |
2022―Aug―11 |
Small molecules targeting endolysosomal acidification and signaling in sepsis and severe SARS-CoV-2 infection/COVID-19 |
Markus Blaess, Oliver Sommerfeld, René Csuk, Hans-Peter Deigner |
24 |
[GO] |
Exploration of Immunology |
2022―Jul―18 |
In COVID-19, antigen size lower or larger than 70 kDa modulates the sepsis and memory B cells |
Francisco Javier Martín Oncina |
25 |
[GO] |
Exploration of Immunology |
2022―May―17 |
SARS-CoV-2: overview of immune response, insights into vaccine platforms and their challenges |
Balram Ji Omar, Arpana Singh, Vanya Singh, Ashish Kothari, Manju O. Pai |
26 |
[GO] |
Exploration of Immunology |
2022―Mar―16 |
High avidity of vaccine-induced immunoglobulin G against SARS-CoV-2: potential relevance for protective humoral immunity |
Georg Bauer |
27 |
[GO] |
Exploration of Immunology |
2022―Feb―11 |
Immune titers of protection against severe acute respiratory syndrome coronavirus 2: are we there yet? |
Yoanna Slabakova, Dilyana Gerenska, Nedelcho Ivanov, Tsvetelina Velikova |
28 |
[GO] |
Exploration of Immunology |
2021―Dec―31 |
State-of-the-art preclinical evaluation of COVID-19 vaccine candidates |
Devlina Ghosh, Bingxin Bai, Qun Ji, Soumya Palliyil, Guang Yang, Alok Kumar, Abhishek Saxena |
29 |
[GO] |
Exploration of Immunology |
2021―Dec―31 |
New variants of SARS-CoV-2, vaccine immune response and the Brazilian reality |
Marileia Andrade, Luiza Gomes, Vitória Mendes, Hellen Rosa |
30 |
[GO] |
Exploration of Immunology |
2021―Dec―14 |
Activation of mucosal immunity and novel prophylactic and therapeutic strategy in combating COVID-19 |
Swapan K. Chatterjee, Snigdha Saha, Maria Nilda M. Munoz |
31 |
[GO] |
Exploration of Immunology |
2021―Dec―13 |
COVID-19 vaccine and immune response |
Sevilay Hintistan, Hatice Demirağ |
32 |
[GO] |
Exploration of Immunology |
2021―Dec―10 |
Vaccine-induced immune responses against SARS-CoV-2 infections |
Mandeep Garg, Muniraju Maralakunte, Yashwant Kumar, Harish Bhujade, Inder Paul Sehgal, Vikas Suri, Suruchi Garg |
33 |
[GO] |
Exploration of Immunology |
2021―Nov―01 |
Viral vector-based vaccines against SARS-CoV-2 |
Kenneth Lundstrom |
34 |
[GO] |
Exploration of Immunology |
2021―Sep―30 |
Immune responses induced by different vaccine platforms against coronavirus disease-19 |
Eknath D. Ahire, Sanjay J Kshirsagar |
35 |
[GO] |
Exploration of Immunology |
2021―Sep―01 |
Severe acute respiratory syndrome coronavirus 2 targeted antibodies cocktail and B cell receptor interplay: interventions to trigger vaccine development |
Kabeer Haneef, Rabia Saleem, Muhammad Saleem Iqbal Khan, Olawale Samuel Adeyinka, Sadeeq Banday, Muhammad Umer Asghar, et al. (+2) Zia Ur Rahman, Zainab Fatima |
36 |
[GO] |
Exploration of Immunology |
2021―Sep―01 |
The protective immunity induced by SARS-CoV-2 infection and vaccination: a critical appraisal |
Eduardo Tosta |
37 |
[GO] |
Exploration of Immunology |
2021―Sep―01 |
Conserved envelope protein of nCoV2 as the possible target to design polytope vaccine |
Krupanidhi Sreerama |
38 |
[GO] |
Exploration of Immunology |
2021―Jul―01 |
Immunopathogenesis of severe acute respiratory syndrome coronavirus-2: evolving knowledge and its current status |
Nitin Saksena, Srinivasa Reddy Bonam, Monica Miranda-Saksena |
39 |
[GO] |
Exploration of Immunology |
2021―Mar―31 |
In silico investigation of binding affinities between human leukocyte antigen class I molecules and SARS-CoV-2 virus spike and ORF1ab proteins |
Spyros A. Charonis, Effie-Photini Tsilibary, Apostolos P. Georgopoulos |
40 |
[GO] |
Exploration of Medicine |
2024―Apr―09 |
The coevolution of Covid-19 and host immunity |
Azizul Haque, Anudeep B. Pant |
41 |
[GO] |
Exploration of Medicine |
2023―Nov―01 |
Figuring the characteristics of the Delta variant SARS-CoV-2 gene mutations in an Indonesian hospital: a descriptive study |
Phey Liana, Muhammad Agung Maulana, Eny Rahmawati, Rouly Pola Pasaribu, Kemas Yakub Rahadiyanto, Nelda Aprilia Salim, Tungki Pratama Umar |
42 |
[GO] |
Exploration of Medicine |
2023―Aug―31 |
Cannabis-based medicinal products (CBMPs) for the treatment of Long COVID symptoms: current and potential applications |
Hannah Thurgur, Anne Katrin Schlag, Elizabeth Iveson, Adele Hosseini, Michael Lynskey, David J. Nutt |
43 |
[GO] |
Exploration of Medicine |
2023―Jun―28 |
The impact of COVID-19 pandemic on diagnosis and management of gastrointestinal cancers |
Byung Soo Yoo, Ankit Patel, Kevin V. Houston, Alejandra Vargas, Ana Rosa Vilela Sangay, Steve M. D’Souza, David A. Johnson |
44 |
[GO] |
Exploration of Medicine |
2023―Jun―28 |
Association between coronavirus 2019 disease and pseudoneurological complaints: analysis of case-control data |
Mohammad Ali, Atia Sharmin Bonna, Tajnuva Mehjabin |
45 |
[GO] |
Exploration of Medicine |
2023―Apr―26 |
Gastrointestinal microbiome and coronavirus disease: evidence of a bidirectional association |
Kevin V. Houston, Ankit Patel, Michael Saadeh, Alejandra Vargas, Ana Rosa Vilela Sangay |
46 |
[GO] |
Exploration of Medicine |
2023―Apr―26 |
Mechanistic approaching study in COVID-19 patients treated with high doses of vitamin D |
Mauro G. Silva, Felipe Inserra, Javier Mariani, Laura Antonietti, Myriam Nuñez, Carlos Tajer, et al. (+10) León Ferder, Pablo I. F. Inserra, Fernando Ross, Milagro Sánchez Cunto, Magalí Bertelli, Gabriela de Larrañaga, Eliana M. Cela, Daniel H. González Maglio, Mariela M. Gironacci, Walter Manucha |
47 |
[GO] |
Exploration of Medicine |
2023―Apr―26 |
Immunomodulation strategies against COVID-19 evidence: key nutrients and dietary approaches |
Lindsey B. Cundra, Manasa Vallabhaneni, Michael Saadeh, Kevin V. Houston, Byung Soo Yoo, Steve D’Souza, David A. Johnsonv |
48 |
[GO] |
Exploration of Medicine |
2023―Mar―01 |
m6 RNA methylation: an emerging common target in the immune response to cancer and severe acute respiratory syndrome-coronavirus-2 infection |
Hiromichi Sato, Tomoaki Hara, Chihiro Otsuka, Yasuko Arao, Yoshiko Tsuji, Yumiko Hamano, et al. (+5) Mirei Ogita, Eric di Luccio, Takaaki Hirotsu, Andrea Vecchione, Hideshi Ishii |
49 |
[GO] |
Exploration of Medicine |
2023―Feb―27 |
Molecular docking analysis of peptide-based antiviral agents against SARS-CoV-2 main protease: an approach towards drug repurposing |
Abhishek Chaurasiya, Abhimannu Shome, Pooja A. Chawla |
50 |
[GO] |
Exploration of Medicine |
2022―Dec―30 |
Incursions by severe acute respiratory syndrome coronavirus-2 on the host anti-viral immunity during mild, moderate, and severe coronavirus disease 2019 disease |
Saksena Nitin, Bonam Srinivasa R., Miranda-Saksena Monica, Cardoso Thyago H. |
51 |
[GO] |
Exploration of Medicine |
2022―Dec―29 |
Right atrial thrombus, junctional tachycardia, and critical lower limb ischemia: three rare complications of severe acute respiratory syndrome coronavirus 2 infection |
Said Makani, Aziza Laarje, Meryem Mabrouk, Younes Zaid, Malak Chahid, Zaynab Hifdi, et al. (+4) Meriem Azhari, Chafik Elkettani, Hicham Belmir, Youssef Tijani |
52 |
[GO] |
Exploration of Medicine |
2022―Jun―09 |
Early taurine administration as a means for halting the cytokine storm progression in COVID-19 patients |
Alberto Rubio-Casillas, Ramesh C. Gupta, Elrashdy M. Redwa, Vladimir N. Uversky, Raied Badierah |
53 |
[GO] |
Exploration of Medicine |
2022―Jan―25 |
Fertility and COVID-19 vaccination |
Iosif M. Gershteyn |
54 |
[GO] |
Exploration of Medicine |
2022―Jan―18 |
Preclinical toxicity test results of a new antiviral-immune-modulator compound consisting of flavonoid molecules (COVID-19 clinical trial preliminary data) |
Gürer G. Budak, Seçil Özkan, Mehmet Budak, Tamay Şeker, Bahar Meryemoglu, Şükran Selin Miran, et al. (+2) Canan Çakır Çoban, Orkun Tarkun |
55 |
[GO] |
Exploration of Medicine |
2021―Dec―31 |
Preclinical toxicity test results of a new antiviral-immune-modulator compound consisting of flavonoid molecules (COVID-19 clinical trial preliminary data) |
Gürer G. Budak, Seçil Özkan, Mehmet Budak, Tamay Şeker, Bahar Meryemoglu, Şükran Selin Miran, et al. (+2) Canan Çakır Çoban, Orkun Tarkun |
56 |
[GO] |
Exploration of Medicine |
2021―Oct―09 |
A review of aortic thrombosis in COVID-19 infection |
Korin Karabulut, Ahmet Kapici, Ana Andronikashvili, James Morgan |
57 |
[GO] |
Exploration of Medicine |
2021―Aug―30 |
High prevalence of false positive SARS-CoV2 serology in a cohort of patients with liver autoimmune diseases |
Maria Giulia Cornacchia, Moris Sangineto, Rosanna Villani, Francesco Cavallone, Giuseppe Di Gioia, Paola Cicciomessere, Gaetano Serviddio |
58 |
[GO] |
Exploration of Medicine |
2021―Apr―27 |
Angiotensin-(3-4) modulates the overweight- and undernutrition-induced ACE2 downregulation in renal proximal tubule cells: implications for COVID-19? |
Rafael Luzes, Humberto Muzi-Filho, Amaury Pereira-Acácio, Thuany Crisóstomo, Adalberto Vieyra |
59 |
[GO] |
Exploration of Medicine |
2020―Oct―31 |
High-performance computing will assist experiments in recovery from COVID-19 |
|
60 |
[GO] |
Exploration of Medicine |
2020―Jul―17 |
Visual communication and learning from COVID-19 to advance preparedness for pandemics |
José de la Fuente, José Bedia, Christian Gortázar |
61 |
[GO] |
Exploration of Neuroprotective Therapy |
2022―Mar―02 |
Subarachnoid hemorrhage: management considerations for COVID-19 |
Eric J. Panther, Brandon Lucke-Wold |
62 |
[GO] |
Exploration of Neuroprotective Therapy |
2021―Apr―20 |
P2X7 receptor involvement in COVID-19 disease |
Peter Illes |
63 |
[GO] |
Exploration of Targeted Anti-tumor Therapy |
2023―Dec―27 |
Telehealth in breast cancer following the coronavirus disease 2019 pandemic |
Jean Zeghondy, Elie Rassy, Pietro Lapidari, Roland Eid, Barbara Pistilli |
64 |
[GO] |
Exploration of Targeted Anti-tumor Therapy |
2023―Oct―31 |
Coronavirus disease 2019 and lung cancer: where are we? |
Abrahams Ocanto, Xabier Mielgo-Rubio, Javier Luna Tirado, Nuria Linares Mesa, Marta López Valcárcel, Sara Pedraza, et al. (+4) Victoria Vera Barragan, Patricia Valencia Nieto, Juan Zafra Martín, Felipe Couñago |
65 |
[GO] |
Exploration of Targeted Anti-tumor Therapy |
2023―Oct―31 |
Impact of coronavirus disease 2019 pandemic on good clinical practice trials in oncology |
Veronica Agostinelli, Zelmira Ballatore, Giulia Ricci, Alessandra Lucarelli, Michela Burattini, Lorenzo Mariotti, et al. (+3) Claudia Catani, Valentina Tarantino, Rossana Berardi |
66 |
[GO] |
Exploration of Targeted Anti-tumor Therapy |
2023―Oct―26 |
A review on in silico virtual screening methods in COVID-19 using anticancer drugs and other natural/chemical inhibitors |
Babak Sokouti |
67 |
[GO] |
Exploration of Targeted Anti-tumor Therapy |
2023―Oct―26 |
Effect of coronavirus disease 2019 on diagnosis and treatment of hepatocellular carcinoma: a systematic review |
Afrooz Mazidimoradi, Samane Sabet Birjandi, Hamid Salehiniya |
68 |
[GO] |
Exploration of Targeted Anti-tumor Therapy |
2023―Sep―07 |
A single experience in the conduction of clinical trial during COronaVIrusDisease-2019 pandemic |
Zelmira Ballatore, Amalia Goudas, Francesco Bozzi, Alessandra Lucarelli, Michela Burattini, Giulia Ricci, et al. (+2) Francesco Savino, Rossana Berardi |
69 |
[GO] |
Exploration of Targeted Anti-tumor Therapy |
2022―Jul―29 |
Consequences of the impact of COVID-19 pandemic on breast cancer at a single Italian institution |
Daniele Ugo Tari, Rosalinda Santonastaso, Fabio Pinto |
70 |
[GO] |
Exploration of Targeted Anti-tumor Therapy |
2022―Jun―10 |
Management of lung cancer patients during COVID-19 pandemic: dos, don’ts and don’t knows |
Mariangela Torniai, Veronica Agostinelli, Luca Cantini, Carolina Liguori, Francesca Morgese, Silvia Rinaldi, et al. (+2) Laura Scortichini, Rossana Berardi |
71 |
[GO] |
Exploration of Targeted Anti-tumor Therapy |
2021―Nov―01 |
Performing oncological procedures during COVID-19 outbreak: a
picture from an Italian cancer center |
Maristella Bungaro, Valentina Bertaglia, Marco Audisio, Elena Parlagreco, Chiara Pisano, Valeria Cetoretta, et al. (+9) Irene Persano, Francesca Jacobs, Chiara Baratelli, Lorena Consito, Maria Reale, Fabrizio Tabbò, Paolo Bironzo, Giorgio Scagliotti, Silvia Novello |